President & Immunovant CEO
Tue, Oct 7, 2025
Oct 7
355,161 shares @ $16.15
Decreased holdings by -19.10%
11th largest trade (out of 285)
Large Trade
Trade made by an officer
10b5-1 scheduled trade
39% win rate · -1.6% median edge vs SPY (69 trades, 90-day)
Price 40% above 200-day moving average